RecruitingNot ApplicableNCT06367257

App-based Recording and Optimization of the Nutritional Status in Patients With Head and Neck Tumors During and After Radio(Chemo)Therapy

Sponsor

University of Erlangen-Nürnberg Medical School

Enrollment

148 participants

Start Date

Feb 29, 2024

Study Type

INTERVENTIONAL

Conditions

Squamous Cell Carcinoma of Head and Neck

Summary

Patients with head and neck cancer requiring definitive or adjuvant radio(chemo)therapy can take part in the study. The aim is to record the nutritional status and diet of the patients during the trial and regularly at a period of 8 weeks after irradiation and to reduce the rate of weight loss and malnutrition.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether a smartphone app (Emento) can help people with head and neck cancer monitor and improve their nutritional status during and after radiation therapy or chemoradiation. **You may be eligible if...** - You have squamous cell carcinoma of the head and neck region - You are receiving radiation therapy (with or without chemotherapy) either after surgery or as your primary treatment - You have a smartphone that can run the Emento app - You are 18 or older **You may NOT be eligible if...** - You have a legal guardian making medical decisions for you - You are not able to participate due to language barriers or other limitations - Your cancer type or treatment plan does not match the study requirements Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREApp Usage

Conducting patient surveys with app

OTHERStandard of Care

supportive care during and after radio(chemo)therapy according to hospial standards

Locations(1)

Universitätsklinikum Erlangen, Strahlenklinik

Erlangen, Bavaria, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06367257

Related Trials

Study on the Efficacy of Treatment by Radiotherapy and Pembrolizumab in Newly Diagnosed Metastatic Head & Neck Cancers

NCT0474705426 locations

A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma

NCT0721921219 locations

A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

NCT07276399198 locations

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

NCT04389632158 locations

A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer

NCT0638508056 locations